Published on 17 Oct 2022 on Simply Wall St. via Yahoo Finance

The past five years for Enzo Biochem (NYSE:ENZ) investors has not been profitable

Long term investing works well, but it doesn't always work for each individual stock. We don't wish catastrophic capital loss on anyone. For example, we sympathize with anyone who was caught holding Enzo Biochem, Inc. (NYSE:ENZ) during the five years that saw its share price drop a whopping 79%. We also note that the stock has performed poorly over the last year, with the share price down 44%. More recently, the share price has dropped a further 21% in a month. But this could be related to poor market conditions -- stocks are down 9.2% in the same time.

Since shareholders are down over the longer term, lets look at the underlying fundamentals over the that time and see if they've been consistent with returns.

Check out our latest analysis for Enzo Biochem